Standout Papers

Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Po... 2010 2026 2015 2020 443
  1. Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer (2010)
    Angelo Di Leo, Guy Jérusalem et al. Journal of Clinical Oncology

Immediate Impact

5 by Nobel laureates 23 from Science/Nature 90 standout
Sub-graph 1 of 21

Citing Papers

Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
2024 Standout
Pan-cancer whole-genome comparison of primary and metastatic solid tumours
2023 StandoutNature
2 intermediate papers

Works of Didier Verhoeven being referenced

Comparing duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial: application of new methodology
2013
Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer
2010 Standout

Author Peers

Author Last Decade Papers Cites
Didier Verhoeven 834 685 318 383 38 1.4k
Daniel Sudilovsky 615 501 253 249 32 1.6k
Armelle Degeorges 767 402 159 558 34 1.6k
E. Kumpulainen 664 261 184 268 41 1.5k
Christopher J. Lafargue 614 813 127 560 30 1.7k
John Winstanley 608 413 141 446 33 1.7k
Cecilia Nisticò 1167 392 227 547 70 1.6k
Guidalberto Fabris 571 319 138 198 46 1.2k
Yajun Yi 385 324 205 490 31 1.7k
M Giai 461 213 260 264 33 1.2k
Pierre Rudolph 601 320 89 332 42 1.4k

All Works

Loading papers...

Rankless by CCL
2026